BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 27533032)

  • 1. Structure-based discovery of opioid analgesics with reduced side effects.
    Manglik A; Lin H; Aryal DK; McCorvy JD; Dengler D; Corder G; Levit A; Kling RC; Bernat V; Hübner H; Huang XP; Sassano MF; Giguère PM; Löber S; Da Duan ; Scherrer G; Kobilka BK; Gmeiner P; Roth BL; Shoichet BK
    Nature; 2016 Sep; 537(7619):185-190. PubMed ID: 27533032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels.
    Yudin Y; Rohacs T
    Br J Pharmacol; 2019 Sep; 176(17):3110-3125. PubMed ID: 31074038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.
    Zhao Z; Huang T; Li J
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.
    Gillis A; Gondin AB; Kliewer A; Sanchez J; Lim HD; Alamein C; Manandhar P; Santiago M; Fritzwanker S; Schmiedel F; Katte TA; Reekie T; Grimsey NL; Kassiou M; Kellam B; Krasel C; Halls ML; Connor M; Lane JR; Schulz S; Christie MJ; Canals M
    Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.
    Hill R; Disney A; Conibear A; Sutcliffe K; Dewey W; Husbands S; Bailey C; Kelly E; Henderson G
    Br J Pharmacol; 2018 Jul; 175(13):2653-2661. PubMed ID: 29582414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation.
    Jiang X; Li S; Zhang H; Wang LL
    Comput Biol Chem; 2021 Feb; 90():107405. PubMed ID: 33184004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
    Ding H; Kiguchi N; Perrey DA; Nguyen T; Czoty PW; Hsu FC; Zhang Y; Ko MC
    Br J Anaesth; 2020 Oct; 125(4):596-604. PubMed ID: 32819621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
    Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
    ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain.
    Chen XT; Pitis P; Liu G; Yuan C; Gotchev D; Cowan CL; Rominger DH; Koblish M; Dewire SM; Crombie AL; Violin JD; Yamashita DS
    J Med Chem; 2013 Oct; 56(20):8019-31. PubMed ID: 24063433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
    Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.
    Kudla L; Bugno R; Skupio U; Wiktorowska L; Solecki W; Wojtas A; Golembiowska K; Zádor F; Benyhe S; Buda S; Makuch W; Przewlocka B; Bojarski AJ; Przewlocki R
    Br J Pharmacol; 2019 Dec; 176(23):4434-4445. PubMed ID: 31347704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
    Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
    Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
    Mafi A; Kim SK; Goddard WA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
    Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
    Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
    Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
    Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
    Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.